Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

A kind of preparation method of cross-linked sodium hyaluronate gel with asymmetric structure

A cross-linked hyaluronic acid, asymmetric technology, used in medical biomaterials, medical field, can solve the problems of low utilization rate of cross-linking agent, difficulty in cross-linking agent removal, etc., to achieve long residual time in the body and improve resistance to enzyme degradation , the effect of improving the utilization rate

Active Publication Date: 2017-12-01
SHANGHAI QISHENG BIOLOGICAL PREPARATION CO LTD +1
View PDF4 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0005] Usually the preparation of cross-linked sodium hyaluronate gel is carried out with a fixed concentration of reactants. In such a reaction, the utilization rate of the cross-linking agent is low. In order to achieve a better cross-linking effect, more cross-linking agents are usually added. Reaction of the cross-linking agent, so that the removal of the cross-linking agent is more difficult

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • A kind of preparation method of cross-linked sodium hyaluronate gel with asymmetric structure

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0020] Prepare 20ml of 1% sodium hydroxide aqueous solution, add 0.02g of cross-linking agent BDDE, mix well, add 2.0g sodium hyaluronate, stir well, put it in a 10°C reaction box, set the dehydration rate to 3% / day , after reacting for 10 days, put it into a 40°C water bath, heat for 2 hours, take out the gel cut into about 0.5g in mass, put it in PBS buffer solution, and perform swelling dialysis to obtain cross-linked sodium hyaluronate gel. 20mg / ml.

Embodiment 2

[0022] Prepare 20ml of 1% sodium hydroxide aqueous solution, add 0.01g of cross-linking agent BDDE, mix well, add 2.0g of sodium hyaluronate, stir well, put it in a 10°C reaction box, set the dehydration rate to 4% / day , after reacting for 10 days, put it into a 40°C water bath, heat for 2 hours, take out the gel cut into about 0.5g in mass, put it in PBS buffer solution, and perform swelling dialysis to obtain cross-linked sodium hyaluronate gel. 20mg / ml.

Embodiment 3

[0024] Prepare 20ml of 1.5% sodium hydroxide aqueous solution, add 0.007g of cross-linking agent BDDE, mix well, add 2.0g of sodium hyaluronate, stir well, put it in a 10°C reaction box, set the dehydration rate to 5% / day , after reacting for 10 days, put it into a 40°C water bath, heat for 2 hours, take out the gel cut into about 0.5g in mass, put it in PBS buffer solution, and perform swelling dialysis to obtain cross-linked sodium hyaluronate gel. 20mg / ml.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention relates to a preparation method for a cross-linked sodium hyaluronate gel with an asymmetric structure. The method comprises the steps: adopting a sodium hyaluronate solution containing a cross-linking agent as a starting material, adding a precious small amount of the cross-linking agent, under conditions of constant temperature and constant humidity, carrying out gradient concentration dehydration, then dialyzing the cross-linked sodium hyaluronate gel in a buffer solution, dialyzing until the gel is no longer expanded, and finally, granulating to obtain the cross-linked sodium hyaluronate gel with the asymmetric structure. The cross-linked sodium hyaluronate obtained by the preparation method provided by the invention has the gradient asymmetric structure in microcosmic scale and shows the characteristics of dense exterior and loose interior; the structure ensures that the cross-linked sodium hyaluronate gel can effectively buffer attacking action of sodium hyaluronate enzymes, the survival time in bodies is greatly extended, and at the same time, excellent biological safety is also showed with precious small addition amount of the cross-linking agent.

Description

technical field [0001] The invention relates to the technical field of medical biomaterials, and relates to a preparation method of a novel cross-linked sodium hyaluronate. The cross-linked sodium hyaluronate is used for medical filling and cosmetology, and belongs to the medical field. Background technique [0002] Sodium hyaluronate is an important component of human and animal skin, vitreous body, joint lubricating fluid and cartilage tissue, which consists of (1-β-4) D - Glucuronic acid and (1-β-3) N -Acetyl- D -Glucosamine disaccharide units are repeatedly connected, and are widely used in repair surgery, eye surgery or as a cosmetic filling material. Sodium hyaluronate has good physical and chemical properties and biocompatibility, but it is rapidly degraded by specific hyaluronidase in vivo, with a half-life of only 2-3 days and a short retention time, which cannot meet the needs of clinical application . Cross-linked sodium hyaluronate is a polymer gel modified b...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): C08J3/24C08L5/08C08K5/41C08K5/1515A61L27/20A61L27/52
Inventor 魏长征奚宏伟蒋丽霞
Owner SHANGHAI QISHENG BIOLOGICAL PREPARATION CO LTD
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products